Marbofloxacin
|
WikiDoc Resources for Marbofloxacin |
|
Articles |
|---|
|
Most recent articles on Marbofloxacin Most cited articles on Marbofloxacin |
|
Media |
|
Powerpoint slides on Marbofloxacin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Marbofloxacin at Clinical Trials.gov Trial results on Marbofloxacin Clinical Trials on Marbofloxacin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Marbofloxacin NICE Guidance on Marbofloxacin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Marbofloxacin Discussion groups on Marbofloxacin Patient Handouts on Marbofloxacin Directions to Hospitals Treating Marbofloxacin Risk calculators and risk factors for Marbofloxacin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Marbofloxacin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Marbofloxacin (IUPAC name: 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol(3,2,1-ij)(4,2,1)benzoxadiazin-6 carboxylic acid), is a potent antibiotic of the fluoroquinolone group. It is used in veterinary medicine under the trade names Marboxyl and Zeniquin. A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon (CAS number 115550-35-1).
Clinical mechanism
Marbofloxacin is a quinolone, and acts by inhibiting bacterial DNA replication. It is effective against enterobacteria, Pasteurella, Pseudomonas and staphylococci.
Application
Marbofloxacin can be used both orally and topically. It is particularly used for infections of the skin, respiratory system and mammary glands, as well as with urinary tract infections in dogs. For dogs, a dose of approximately 2 mg/kg is used. The duration of treatment is usually at least five days, longer if there is a concurrent fungal or yeast infection.
Contraindications and side effects
Marbofloxacin should usually be avoided in young animals, during pregnancy where central nervous system accumulation can occur, or when there is an existing kidney problem. Under certain conditions it can cause discomfort such as cramps, treatable with Valium. Other side effects are vomiting and anorexia.